Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

Regorafenib  -  BAY 73-4506

 

 

CAS 755037-03-7

C21H15ClF4N4O3  MW 482.82 

Purity: 99%

Soluble in DMSO to 100 mM 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1678   Prime Source

 

Qty1: 5 mg (research sample) / €115  $150

Qty2: 10 mg (research sample) / €160  $208

Qty3: 50 mg (research sample) / €640  $832

 

Qty4: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for payment and tech support.

Biological Activity:

 

an oral multi-kinase inhibitor which targets angiogenic, stromal and oncogenic receptor tyrosine kinases (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.

 

References: online

 

SM Wilhelm et al. Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int. J. Cancer. 2011, 129(1), 245-55. [online]

 

 

Chemical Name: 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide

 

Regorafenib - BAY 73-4506 | Multikinase inhibitor | Axon Medchem | Axon 1678 | BAY73-9006 - BAY 734506 - BAY734506

 

Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.

axonmedchem.com © 2012

 

Axon Ligands In The Field:

 

Axitinib | VEGFR inhibitor

Cediranib | VEGFR inhibitor

Pazopanib | RTK inhiitor

Regorafenib | RTK inhibitor

Sorafenib | RTK inhibitor

Sunitinib | RTK inhibitor

Vandetanib | VEGFR/EGFR inh.

 

Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection